Fidelis Capital Partners’s Novo Nordisk NVO Stock Holding History

Fidelis Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$210K	Sell
2025 Q2	$218K	Buy
2025 Q1	$260K	Sell
2024 Q4	$1.18M	Sell
2024 Q3	$2.35M	Buy
2024 Q2	$1.17M	Buy
2024 Q1	$1.19M	Buy